GemVax & KAEL Co (XKRX:082270) Days Sales Outstanding : 29.13 (As of Sep. 2024)

View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Days Sales Outstanding?

GemVax & KAEL Co's average Accounts Receivable for the three months ended in Sep. 2024 was ₩4,065 Mil. GemVax & KAEL Co's Revenue for the three months ended in Sep. 2024 was ₩12,735 Mil. Hence, GemVax & KAEL Co's Days Sales Outstanding for the three months ended in Sep. 2024 was 29.13.

The historical rank and industry rank for GemVax & KAEL Co's Days Sales Outstanding or its related term are showing as below:

XKRX:082270' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.9 Med: 40.66 Max: 139.23
Current: 27.28

During the past 13 years, GemVax & KAEL Co's highest Days Sales Outstanding was 139.23. The lowest was 21.90. And the median was 40.66.

XKRX:082270's Days Sales Outstanding is ranked better than
92.22% of 990 companies
in the Semiconductors industry
Industry Median: 63.125 vs XKRX:082270: 27.28

GemVax & KAEL Co's Days Sales Outstanding declined from Sep. 2023 (31.93) to Sep. 2024 (29.13).

GemVax & KAEL Co Days Sales Outstanding Historical Data

The historical data trend for GemVax & KAEL Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Days Sales Outstanding Chart

GemVax & KAEL Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

59.74

32.18

34.28

25.68

21.90

GemVax & KAEL Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															31.93	24.73	31.63	24.35	29.13

Competitive Comparison of GemVax & KAEL Co's Days Sales Outstanding

For the Semiconductor Equipment & Materials subindustry, GemVax & KAEL Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GemVax & KAEL Co's Days Sales Outstanding Distribution in the Semiconductors Industry

For the Semiconductors industry and Technology sector, GemVax & KAEL Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where GemVax & KAEL Co's Days Sales Outstanding falls into.

GemVax & KAEL Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

GemVax & KAEL Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3842.837	+	4823.046)	/	2 )	/	72208.573	*	365
=	4332.9415					/	72208.573	*	365
=	21.90

GemVax & KAEL Co's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (3656.412	+	4473.651)	/	2 )	/	12735.421	*	365 / 4
=	4065.0315					/	12735.421	*	365 / 4
=	29.13

GemVax & KAEL Co (XKRX:082270) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

GemVax & KAEL Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of GemVax & KAEL Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

GemVax & KAEL Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510

Website

http://www.kael.co.kr

GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines